购物车
- 全部删除
- 您的购物车当前为空
PGS-IN-1 (KME-4)是一种前列腺素合成酶抑制剂,IC50=0.28 μM。它也可抑制5-脂肪氧合酶的活性,IC50=1.05 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
PGS-IN-1 (KME-4)是一种前列腺素合成酶抑制剂,IC50=0.28 μM。它也可抑制5-脂肪氧合酶的活性,IC50=1.05 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,230 | 现货 | |
5 mg | ¥ 2,480 | 现货 | |
10 mg | ¥ 3,730 | 现货 | |
25 mg | ¥ 5,970 | 现货 | |
50 mg | ¥ 7,880 | 现货 | |
100 mg | ¥ 10,800 | 现货 |
产品描述 | PGS-IN-1 (KME-4) is a potent inhibitor of prostaglandin synthetase (PGS, IC50: 0.28 μM) and 5-lipoxygenase (IC50: 1.05 μM). |
靶点活性 | PGS:0.28 μM, 5-LOX:1.05 μM |
体外活性 | PGS-IN-1 is the trans isomer of the synthesized α-benzulidene-γ-butyrolactone. PGS-IN-1 exhibits potent anti-inflammatory and PGS inhibitory activity with IC50 of 0.28 μM[1]. PGS-IN-1 also shows potent inhibitory activity against 5-lipoxygenase with IC50 of 1.05 μM[1]. |
别名 | KME-4 |
分子量 | 302.41 |
分子式 | C19H26O3 |
CAS No. | 102271-49-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/ml (181.87 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.